Comparative effectiveness and safety between dabigatran and rivaroxaban in routine practice

• At: Glasgow (Scotland) (2018)
• Type: Poster
• Poster code: POS-HPS-033
• By: CHIOU, Chun-Chi (Kaohsiung Chang Gung Memorial Hospital, Department of Pharmacy)
• Co-author(s): Chun-Chi Chiou: Department of Pharmacy, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City, Taiwan, Province of China
  Chien-Ning Hsu: Department of Pharmacy, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City, Taiwan, Province of China
  Ching-Ling Tai: Department of Pharmacy, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City, Taiwan, Province of China
  Yu-Chin Wang: Department of Pharmacy, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City, Taiwan, Province of China
  
• Abstract:

  Background

  There are conflicting opinions regarding the efficacy and safety of NOACs in Asian population with atrial fibrillation (AF).

  Methods

  AF patients newly (no prior oral anticoagulants ≤ 180 days) initiated with warfarin (n=5981), dabigatran (n=1609) or rivaroxaban (n=2525) were identified using electronic medical records derived from the
  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login